U.S. Postbiotics Market

Market Definition

The postbiotics market comprises products containing inanimate microorganisms and their cellular components that provide health benefits to the users. These products find applicability across dietary supplements, functional foods, pharmaceuticals, animal feed and personal care. The market covers a comprehensive analysis of growth trends and emerging applications targeted at regulating gut health, modulate immune system, and maintain a healthy balance of gut bacteria.

Postbiotics Market Overview

The U.S. postbiotics market was valued at USD 37.4 million in 2025 and is projected to reach USD 94.3 million by 2033, representing a CAGR of 12.49% over the forecast period. Market growth is driven by rising consumer awareness of the benefits of postbiotics for digestive health and overall wellness. This is leading to increased demand for postbiotic ingredients in various formulations, including nutritional supplements, functional foods and beverages​.

Major players operating in the market comprise ADM, International Flavors & Fragrances Inc., Cargill, Incorporated, DSM-Firmenich AG, Kerry Group plc, AB-BIOTICS, SA, ABF Ingredients, Novonesis Group, Lallemand Inc., Kemin Industries, Inc., Morinaga Nutritional Foods, KYOWA HAKKO U.S.A., INC., Sabinsa Corporation, Danone, Stratum Nutrition. Industry players are investing in new flavors and formulation development to enhance the appeal and accessibility of postbiotic products​ in the U.S.

• In June 2025, DSM-Firmenich launched GutServ Biotics, a postbiotic developed to strengthen gut integrity and overall gut functionality in livestock. The product finds wide applicability across swine, poultry, ruminants, and aquaculture to support nutrient absorption, immune balance, and microbiome stability.

Key Market Highlights:

1. The U.S. postbiotics market size was recorded at USD 37.4 million in 2025.
2. The market is projected to grow at a CAGR of 12.49% from 2026 to 2033.
3. The bacteria-derived postbiotics segment captured the highest share of 53% and garnered USD 19.8 million in revenue in 2025.
4. The dry form segment captured the largest share of 80.14% and is valued at USD 30 million in 2025.
5. The functional food and beverages application is anticipated to grow at the highest CAGR of 15.24% over the forecast period.

How is consumer demand for functional foods driving the growth of postbiotics market in the U.S.?

The rising popularity of postbiotics in the U.S. is attributed to their enhanced stability and longer shelf life, leading to reduced risk associated with live microbial consumption, such as potential pathogen transmission and antimicrobial resistance. Rising consumer demand for functional foods with better stability, longer shelf life, and lower risk of infection compared to live microbes is driving postbiotics market growth in the U.S. The inclusion of inanimate microbes in postbiotics eliminates the risk of infections enabling them survive harsh stomach acids and reach the intestines to deliver targeted health benefits.

The property further enables postbiotics to withstand heat, thus making them applicable in wider nutrition innovation, processing, and shelf-stable formats compared to probiotics. This drives their applicability in the food industry for bio-preservation and treating gastrointestinal disorders in pharmaceutical and biomedical fields targeted at enhancing immune functions, further driving market development. Additionally, the demand for safe and effective functional foods addressing sub-health conditions, promoting general well-being, and managing gastrointestinal issues such as diarrhea and bloating further act as major propellers for postbiotics market development in the U.S. 

• In February 2025, Resbiotic launched resM GLP-1 Postbiotic which is designed to support gut health and metabolic balance by leveraging postbiotic metabolites that modulate GLP-1. The formula aims to enhance GLP-1 levels, support weight management, reduce cravings, and promote healthy blood-sugar regulation.

How do scalability challenges in postbiotic production negatively impact market growth?

Key challenges comprise maintenance of consistent production yield, as microbial strains that perform efficiently in controlled laboratory conditions often exhibit variable metabolite production when transferred to large-scale fermentation systems. Moreover, the high cost of substrates and downstream processing facilities, including purification, drying, and packaging, adds to the overall cost of postbiotics at industrial volumes, thus restraining market growth avenues.

To address the challenge, postbiotic manufacturers are investing in process optimization, automation, advanced stabilization technologies, and efficient production systems to achieve cost-effective and scalable postbiotic manufacturing while maintaining product efficacy and quality.

• In May 2026, Probi (Symrise Group) expanded its microbiome portfolio by launching its first postbiotic, Rham271h, at Vitafoods Europe, thus marking its entry in the postbiotic market. The solution is derived from Lacticaseibacillus rhamnosus 271 and offers enhanced heat, pH, and shelf stability while retaining immune-supporting properties. 

• In March 2026, Cargill Animal Nutrition & Health enhanced its Cedar Rapids facility in the U.S. with a USD 3.5 million investment in infrastructure upgrades to enable postbiotic fermentation and boost capacity. 

How is the development of specialized formats emerging as a notable trend in the postbiotics market?

The rise in consumer demand for convenience, improved compliance, enhanced product stability, and targeted health benefits is enabling manufacturers to expand postbiotic delivery forms beyond conventional capsules, tablets, and powder formulations. Market players are introducing innovative postbiotic products in gummies, chewable tablets or orally disintegrating tablet (ODT) formats.

Furthermore, the demand for orally disintegrating tablets, fast-melt formats or quick-dissolve formats due to their rapid dissolution and convenient administration is gaining widespread adoption in the market. Additionally, the demand for effervescent postbiotic forms is further gaining popularity due to their enhanced sensory appeal and ease of consumption, while functional foods and beverages fortified with postbiotics are expanding opportunities for daily health management and preventive nutrition.

• In June 2025, Nature’s Bounty launched Prebiotic + Postbiotic + Probiotic Gummies formulated to support a healthy gut, regularity, and immune function. The gummies are fused with Immuno-LP20, Lactobacillus plantarum, and SNZ 1969 Bacillus coagulans, which aid in easing occasional gut discomfort, including gas and bloating.
• In March 2025, TopGum launched Gummiotics, which is a sugar-free synbiotic gummy that combines prebiotics, probiotics, and postbiotics in a single formulation. The product is designed to support gut health and immune function while addressing stability challenges commonly associated with probiotic gummy supplements.
• In September 2024, SIRIO Pharma launched the GummiBiotics range, which includes three gummy supplements targeting immune health, irritable bowel syndrome (IBS) symptom management, and weight management.

Postbiotics Market Report Snapshot

 Market Segmentation

• By Source: (Bacteria-Derived (Lactobacillus, Bifidobacterium, Others), Yeast-Derived (Saccharomyces, Cerevisiae, Saccharomyces Boulardii, Others). The bacteria-derived source captures the highest market share of 53% in 2025 with a valuation of USD 19.8 million. The superior stability and widespread use in dietary supplements, functional foods, and animal nutrition products drive its strong commercial adoption and consumer demand. 

• By Form: (Dry and Liquid). The dry form captured the highest share of 80.14% and was valued at USD 30 million in 2025. The growth of dry postbiotics is attributed to their longer shelf life, greater stability during storage and transportation, ease of incorporation into supplement and food formulations, and cost-effective manufacturing processes. 

• By Application: (Functional Food and Beverages, Dietary Supplements, Animal Feed and Pet Care, Cosmetics and Personal Care, Pharmaceuticals, Others). The functional food and beverages application is anticipated to grow at the highest CAGR of 15.24% over the forecast period. The high growth rate is attributed to the rising consumer demand for microbiome-friendly gut care ingredients in functional foods and beverages that provide anti-inflammatory benefits and promote overall digestive health. 

 What is the market scenario of postbiotics in the U.S.?

The U.S. postbiotics market was valued at USD 37.4 million in 2025 and is anticipated to register a CAGR of 12.49% over the forecast period, reaching USD 94.3 million in 2033. The country is designated as the major consumer of gut health and functional nutrition-driving products. The demand for postbiotics is led by food and beverage manufacturers, dietary supplement brands, and pharmaceutical formulators, which are driving product adoption through their inclusion in functional foods, protein powders, and digestive health supplements.

Additionally, expanding interest in immune health and digestive wellness continues to drive sustained demand across the U.S. For instance, colon and rectal cancer (CRC) is denoted as the third most commonly diagnosed cancer and the second leading cause of cancer-related death in the U.S. This fuels the demand for wellness substances that strengthen the protective lining of gut and help regulate the body's immune response.

• In June 2026, Plexus Worldwide, LLC launched Plexus Armor which is a daily supplement designed to strengthen and protect the gut lining. The product combines A2 colostrum, L-glutamine, prebiotic fiber, postbiotics, and botanicals to support digestion, immune health, and microbiome balance. 

Regulatory Frameworks

• The U.S. Food and Drug Administration (FDA) mandates dietary supplements to list different types of ingredients on labels. The regulatory framework further ensures that manufacturers strictly adhere to product safety, quality, and accurate labeling.
• The U.S. Federal Trade Commission (FTC) issues guidelines for the advertising of dietary supplements and other health-related products. It emphasizes that all advertising claims for dietary supplements are to be non-misleading and supported by competent and reliable scientific evidence. 

Competitive Landscape

Key players operating in the postbiotics market, including ADM, International Flavors & Fragrances Inc., Cargill, DSM-Firmenich AG, Kerry Group plc, AB-BIOTICS, SA, ABF Ingredients, Novonesis Group, Lallemand Inc., Kemin Industries, Inc., Sabinsa Corporation, and others, are focusing on strengthening their market position through technological innovation, strategic partnerships, and production capacity expansion. Companies are increasing investments in microbiome research, clinically validated postbiotic strains, and advanced fermentation technologies to develop targeted solutions for digestive health, immune support, metabolic health, and overall wellness.

Market participants are further actively engaging in strategic mergers, acquisitions, and joint ventures to expand their footprint in the U.S. The move enables them to enhance production capabilities and diversify their product portfolios with the development of innovative delivery formats, including gummies, chewable tablets, capsules, powders, stick packs, and functional food and beverage applications, to improve consumer convenience and product differentiation.

• In July 2025, Danone acquired The Akkermansia Company (TAC) which is a Belgian manufacturer of postbiotic products. The acquisition is targeted at providing resources to TAC to accelerate global growth of the pasteurized Akkermansia muciniphila MucT strain and develop brands at a faster pace. 

• In July 2023, DSM-Firmenich AG acquired Adare Biome which is a specialist in postbiotics, for approximately USD 319 million. The deal targets strengthening the global reach of Firmenich to scale and commercialize Adare Biome’s postbiotic solutions. 

Key Companies In The U.S. Postbiotics Market :

• ADM
• International Flavors & Fragrances Inc.
• Cargill, Incorporated
• DSM-Firmenich AG
• Kerry Group plc
• AB-BIOTICS, SA
• ABF Ingredients
• Novonesis Group
• Lallemand Inc.
• Kemin Industries, Inc.
• Morinaga Nutritional Foods
• KYOWA HAKKO U.S.A., INC.
• Sabinsa Corporation
• Danone
• Stratum Nutrition

 Recent Developments 

• In May 2025, Lallemand Health Solutions partnered with Kirin Holdings to distribute IMMUSE postbiotic supplement. The product comprises clinically researched, heat-inactivated Lactococcus lactis strain Plasma. The strain directly activates key immune cells called plasmacytoid dendritic cells, thus offering comprehensive immune support by stimulating both innate and adaptive immune responses. 

• In May 2025, Bon Natural Life Limited (BON) announced an exclusive cooperation agreement of 36 months with Beijing Huahai Keyuan (Tech) Co., Ltd. with a valuation of USD 32 million. The deal enables Beijing Huahai Keyuan as the exclusive sales partner for the patented postbiotic ingredient of BON. 

• In March 2025, TopGum Industries launched Gummiotics, which is a sugar-free synbiotic gummy combining prebiotics, spore-forming probiotics and BPL1 postbiotic in a patent-pending Gummiceuticals fiber matrix. The clean label non-GMO gummies are designed for stability without refrigeration, zero added sugars and available in certified (kosher/halal) formulations. 

• In March 2025, Puratos announced Postbiotics Inc. as the winner of its Gut Health Innovation Challenge in partnership with Future Food-Tech. The product postbiotic Pozibio offered enhanced gut wall protection, reduced systemic inflammation, and resistance to heat with a neutral flavor. 

• In February 2025, ADM signed an agreement with Asahi Group Foods to market and distribute the postbiotic Lactobacillus gasseri CP2305 globally, excluding Japan. The ingredient supports stress reduction, mood improvement, and better sleep quality through the gut-brain axis.